MedPath

Evaluation of clinical efficacy and sustainability of COVID-19 booster vaccination in patients with hematological diseases.

Not Applicable
Conditions
hematological diseases
Registration Number
JPRN-UMIN000048764
Lead Sponsor
Blood Disorders Center, Aiiku Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
600
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are judged to be ineligible for the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath